1-20 of 247
Sherry Pierce
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia

Mehrnoosh Tashakori, Tapan Kadia, Sanam Loghavi, Naval Daver, Rashmi Kanagal-Shamanna, Sherry Pierce, Dawen Sui, Peng Wei, Farnoosh Khodakarami, Zhenya Tang, Mark Routbort, Carol A. Bivins, Elias J. Jabbour, L. Jeffrey Medeiros, Kapil Bhalla, Hagop M. Kantarjian, Farhad Ravandi, Joseph D. Khoury
Journal: Blood
Blood (2022) 140 (1): 58–72.
DOI: https://doi.org/10.1182/blood.2021013983
Published: 2022
Includes: Supplemental data
Journal Articles

Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm

Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, Nitin Jain, Naval Daver, Sherry Pierce, Elias Jabbour, Tapan Kadia, Courtney DiNardo, Guillermo Garcia-Manero, Muzaffar Qazilbash, Marina Konopleva, Hagop Kantarjian
Journal: Blood
Blood (2021) 138 (15): 1373–1377.
DOI: https://doi.org/10.1182/blood.2021011817
Published: 2021
Journal Articles

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

Clinical Trials & Observations
Naveen Pemmaraju, Hagop Kantarjian, Loretta Nastoupil, Megan Dupuis, Lisa Zhou, Sherry Pierce, Keyur P. Patel, Lucia Masarova, Jorge Cortes, Srdan Verstovsek
Journal: Blood
Blood (2019) 133 (21): 2348–2351.
DOI: https://doi.org/10.1182/blood-2019-01-897637
Published: 2019
Journal Articles

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Clinical Trials & Observations
Lucia Masarova, Srdan Verstovsek, Juliana E. Hidalgo-Lopez, Naveen Pemmaraju, Prithviraj Bose, Zeev Estrov, Elias J. Jabbour, Farhad Ravandi-Kashani, Koichi Takahashi, Jorge E. Cortes, Jing Ning, Maro Ohanian, Yesid Alvarado, Lingsha Zhou, Sherry Pierce, Romany Gergis, Keyur P. Patel, Rajyalakshmi Luthra, Tapan M. Kadia, Courtney D. DiNardo, Gautam Borthakur, Kapil Bhalla, Guillermo Garcia-Manero, Carlos E. Bueso-Ramos, Hagop M. Kantarjian, Naval Daver
Journal: Blood
Blood (2018) 132 (16): 1664–1674.
DOI: https://doi.org/10.1182/blood-2018-04-846626
Published: 2018
Includes: Supplemental data
Journal Articles

A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia

Nicholas J Short, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Tapan Kadia, MD, Xuelin Huang, PhD, Naval Daver, MD, Courtney D. DiNardo, MDMSc, Alessandra Ferrajoli, MD, William G Wierda, MD PhD, Zeev Estrov, MD, Christopher B Benton, MD, Prithviraj Bose, MD, Yesid Alvarado, MD, Steven Kornblau, MD, Maro Ohanian, DO, Yvonne Gaisor, Mary Ann Richie, Sherry Pierce, Elias J. Jabbour, MD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2577.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2577.2577
Published: 2017
Journal Articles

The Prognostic Significance of Translocation (1;19) in Adult Patients (Pts) with B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Devendra KC, MD, Mary Abisola Akosile, PhD, Joseph David Khoury, MD, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, William G Wierda, MD PhD, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Sherry Pierce, BSN, BA, Susan M. O'Brien, MD, Elias J. Jabbour, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2712.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2712.2712
Published: 2017
Journal Articles

CD123 Expression Patterns and Potential of IMGN632, a CD123-Targeted Antibody Drug Conjugate, in Acute Lymphoblastic Leukemia

Evgeniya Angelova, MD PhD, Charlene Audette, Yelena Kovtun, PhD, Naval Daver, MD, Sa A. Wang, MD, Sherry Pierce, BSN, BA, Sergej Naumovich Konoplev, MD PhD, Jeffrey L. Jorgensen, MD PhD, Marina Konopleva, MD PhD, Patrick A. Zweidler-McKay, MDPhD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Joseph David Khoury, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2718.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2718.2718
Published: 2017
Journal Articles

Sotatercept (ACE-011) Alone and in Combination with Ruxolitinib in Patients (pts) with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia

Prithviraj Bose, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, Zeev Estrov, MD, Allison Pike, RN, Julie Huynh-Lu, Physician Assistant, Madeleine Nguyen-Cao, Physician Assistant, Xuemei Wang, Lingsha Zhou, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 255.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.255.255
Published: 2017
Journal Articles

Phase IB/II Study of Lirilumab with Azacytidine (AZA) in Relapsed AML

Naval Daver, MD, Prajwal Boddu, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Elias J. Jabbour, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, Marina Konopleva, MD PhD, Naveen Pemmaraju, MD, Tapan Kadia, MD, Nitin Jain, MD, Sherry Pierce, BSN, BA, Wilmer Flores, Steven Kornblau, MD, Nawar Hussain, Jing Ning, PhD, Graciela Nogueras González, Sreyashi Basu, Jorge E. Cortes, MD, Padmanee Sharma, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2634.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2634.2634
Published: 2017
Journal Articles

Interim Phase 2 Clinical Trial Results for LCL161, an Oral Smac Mimetic, in Patients with Intermediate or High Risk Myelofibrosis

Naveen Pemmaraju, MD, Bing Z Carter, PhD, Hagop M. Kantarjian, MD, Prithviraj Bose, MD, Tapan Kadia, MD, Elias J. Jabbour, MD, Courtney D. DiNardo, MDMSc, Naval Daver, MD, Zeev Estrov, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Lingsha Zhou, Po Yee Mak, Karina Salinas, RN, Carla Kay Tuttle, RN, Sherry Pierce, BSN, BA, Uday Popat, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 256.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.256.256
Published: 2017
Journal Articles

Phase 2 Study of Pracinostat in Combination with Ruxolitinib in Patients (pts) with Myelofibrosis (MF)

Prithviraj Bose, MD, Naveen Pemmaraju, MD, Kurt Schroeder, Alessandra Ferrajoli, MD, Elias J. Jabbour, MD, Naval Daver, MD, Courtney D. DiNardo, MDMSc, Yesid Alvarado, MD, Musa Yilmaz, MD, Julie Huynh-Lu, Physician Assistant, Wei Qiao, PhD, Xuemei Wang, Aurelio Matamoros, Lingsha Zhou, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1632.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1632.1632
Published: 2017
Journal Articles

Dynamics of Measurable Disease at Remission Determines Survival in Patients (Pts) with Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Elias J. Jabbour, MD, Xuemei Wang, Sanam Loghavi, MD, Joseph David Khoury, MD, Jeffrey L. Jorgensen, MD PhD, Farhad Ravandi, MBBS, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Koichi Takahashi, MD, Maria Khouri, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Rebecca Garris, Msc, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1434.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1434.1434
Published: 2017
Journal Articles

Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Xuemei Wang, Devendra KC, MD, Joseph David Khoury, MD, Farhad Ravandi, MBBS, Nicholas J Short, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, William G Wierda, MD PhD, Maria Khouri, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Rebecca Garris, Msc, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1435.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1435.1435
Published: 2017
Journal Articles

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, William G Wierda, MD PhD, Naval Daver, MD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Mary B. Rios, RN, Sherry Pierce, BSN, BA, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1609.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1609.1609
Published: 2017
Journal Articles

JAK2 Variants Associated with Secondary-AML from MPN

Christopher B Benton, MD, Prajwal C Boddu, MD, Courtney D. DiNardo, MDMSc, Prithviraj Bose, MD, Feng Wang, PhD, Naveen Pemmaraju, MD, Devendra KC, MD, Sherry Pierce, BSN, BA, Keyur P. Patel, MBBS, PhD, Marina Konopleva, MD PhD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 305.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.305.305
Published: 2017
Journal Articles

Phase 2 Study of Combination of Cytarabine, Idarubicin, and Nivolumab for Initial Therapy of Patients with Newly Diagnosed Acute Myeloid Leukemia

Farhad Ravandi, MBBS, Naval Daver, MD, Guillermo Garcia-Manero, MD, Christopher B Benton, MD, Philip A Thompson, MBBS, Gautam Borthakur, MD, Tapan Kadia, MD, Prajwal C Boddu, MD, Yesid Alvarado, MD, Elias J. Jabbour, MD, Marina Konopleva, MD PhD, Koichi Takahashi, MD, Steven Kornblau, MD, Courtney D. DiNardo, MDMSc, Zeev Estrov, MD, Wilmer Flores, Sreyashi Basu, James Allison, PhD, Padmanee Sharma, MD PhD, Sherry Pierce, Mark Brandt, Allison Pike, RN, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Suppl_1): 815.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.815.815
Published: 2017
Journal Articles

Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or PD-1 Blockade

Betul Oran, MDMS, Guillermo Garcia-Manero, MD, Rima M. Saliba, PhD, Gheath Alatrash, DO, PhD, Elias J. Jabbour, MD, Uday Popat, MD, Farhad Ravandi, MBBS, Amin M. Alousi, Tapan Kadia, MD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Sherry Pierce, BSN, BA, Katy Rezvani, MD PhD, Elizabeth J Shpall, MD, Padmanee Sharma, MD PhD, Richard E. Champlin, MD, Hagop M. Kantarjian, MD, Naval Daver, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3209.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3209.3209
Published: 2017
Journal Articles

The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial

Rita Assi, MD, Prithviraj Bose, MD, Srdan Verstovsek, MD PhD, Yvonne Gasior, RN, Nitin Jain, MD, Elias J. Jabbour, MD, Zeev Estrov, MD, Yesid Alvarado, MD, Courtney D. DiNardo, MDMSc, Naveen Pemmaraju, MD, Steven Kornblau, MD, Tapan Kadia, MD, Naval Daver, MD, Mark Brandt, BS, Sherry Pierce, BSN, BA, Xuelin Huang, PhD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1379.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1379.1379
Published: 2017
Journal Articles

JAK3 Variants in Adults with Myeloid Malignancies and Potential for Response to JAK3 Inhibition

Rita Assi, MD, Christopher B Benton, MD, Ahmed Al Rawi, Kamal Chamoun, MD, Feng Wang, PhD, Sherry Pierce, BSN, BA, Keyur P. Patel, MBBS, PhD, Betty K. Hamilton, MD, Courtney D. DiNardo, MDMSc, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Tapan Kadia, MD, Srdan Verstovsek, MD PhD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1381.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1381.1381
Published: 2017
Journal Articles

a Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)

Naval Daver, MD, Rita Assi, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Elias J. Jabbour, MD, Courtney D. DiNardo, MDMSc, Tapan Kadia, MD, Jing Ning, PhD, Graciela Nogueras González, Sherry Pierce, BSN, BA, Mary Kelly, Weiguo Zhang, MD PhD, Dan Gombos, MD, Steven Kornblau, MD, Marina Konopleva, MD PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1344.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1344.1344
Published: 2017